DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

LinksSchließen

Referenz

Desai A, Kovanda L, Kowalski D, Lu Q, Townsend R, Bonate PL.
Population pharmacokinetics of isavuconazole from phase 1 and phase 3 (SECURE) trials in adults and target attainment in patients with invasive infections due to Aspergillus and other filamentous fungi.

Antimicrob Agents Chemother 2016;
60 (09) 5483-5491

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: